The potentially multi-billion-dollar kefir market in the U.S. is dominated by one company, this month’s Cabot Small-Cap Confidential investment candidate, Lifeway (LWAY). As the leading manufacturer of cultured, probiotic, functional dairy goods and kefir-related health foods, Lifeway has the potential to eclipse yogurt in the probiotics market as consumers, led by the fast-growing Baby Boomers, become increasingly aware of gastrointestinal (GI) tract health.
